🔗 Share this article

Treasury head Reeves has revealed she is preparing "focused action to deal with cost of living pressures" in the forthcoming financial statement.

Speaking to media outlets, she emphasized that reducing price rises is a collective responsibility of both the government and the central bank.

The United Kingdom's inflation rate is expected to be the most elevated among the G7 industrialized countries this year and the following year.

Possible Energy Cost Measures

It is understood the administration could intervene to lower utility costs, such as by reducing the current 5% rate of VAT charged on energy.

A further approach is to reduce some of the regulatory levies currently added to bills.

Fiscal Limitations and Analyst Expectations

The administration will receive the latest assessment from the independent fiscal watchdog, the OBR, on Monday, which will clarify how much room there is for these actions.

The consensus from most analysts is that Reeves will have to introduce tax increases or expenditure reductions in order to fulfill her declared fiscal targets.

Previously on the same day, estimates showed there was a twenty-two billion pound shortfall for the chancellor to fill, which is at the more modest range of expectations.

"It is a joint task between the Bank of England and the administration to continue tackling some of the causes of inflation," the Chancellor informed the BBC in Washington, at the annual meetings of the International Monetary Fund and global financial institution.

Revenue Pledges and International Issues

While much of the attention has been on probable tax increases, the chancellor said the latest information from the fiscal watchdog had not altered her commitment to campaign commitments not to increase tax levels on earnings tax, VAT or social security contributions.

She attributed an "uncertain global environment" with growing international and trade concerns for the Budget tax moves, probably to be focused on those "most able to pay."

International Economic Tensions

Commenting on concerns about the UK's economic relations with the Asian nation she said: "Our national security invariably are paramount."

Last week's announcement by Chinese authorities to increase trade restrictions on critical minerals and other resources that are crucial for advanced tech production led American leader the US President to threaten an additional 100% tariff on imports from China, raising the prospect of an all-out trade war between the two global powers.

The US Treasury Secretary called the Chinese move "commercial pressure" and "a global supply chain control attempt."

Inquired about accepting the American proposal to join its conflict with China, the Chancellor said she was "deeply worried" by Chinese measures and urged the Beijing authorities "not to put up barriers and limit trade."

She said the decision was "harmful for the global economy and generates further challenges."

"It is my opinion there are areas where we must address China, but there are also important chances to trade with China's economy, including financial services and other areas of the economy. We've got to maintain that balance right."

The Treasury chief also confirmed she was working with other major economies "regarding our own critical minerals plan, so that we are less reliant."

Health Service Drug Pricing and Investment

Reeves also admitted that the price the NHS pays for medicines could increase as a consequence of current discussions with the Trump administration and its drugs companies, in return for lower tariffs and investment.

A number of the world's largest drug companies have said recently that they are either halting or abandoning investments in the United Kingdom, with some attributing the insufficient payments they are getting.

Last month, the Science Minister said the cost the health service spends on drugs would must go up to prevent companies and drug research funding departing from the United Kingdom.

Reeves told the BBC: "It has been observed due to the pricing regime, that clinical trials, innovative medicines have not been offered in the UK in the manner that they are in other EU nations."

"The objective is to ensure that individuals receiving treatment from the National Health Service are able to access the finest life-saving treatments in the world. And so we are looking at all of that, and... aiming to obtain additional funding into Britain."